Honorary Professor of Pharmacology, UNSW

Book Chapters:

Day R; graham GG, 2016, 'Coxibs', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1 - 7, http://dx.doi.org/10.1007/978-3-0348-0620-6_22-1

Day R; pile KD; graham GG; katelaris C, 2016, 'Antimalarial Drugs', in Compendium of Inflammatory Diseases, Springer Basel, Basel, pp. 97 - 101, http://dx.doi.org/10.1007/978-3-7643-8550-7

Day RO; Williams KM; Graham GG, 2013, 'Urate-lowering therapy: Uricosurics', in Gout, pp. 174 - 189, http://dx.doi.org/10.2217/EBO.13.104

Graham GG; Day RO, 2013, 'Salicylates', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Graham GG; Williams KM, 2013, 'Propionic acid derivative drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Journal articles:

Kannangara DRW; Graham GG; Wright DFB; Stocker SL; Portek I; Pile KD; Barclay ML; Williams KM; Stamp LK; Day RO, 2017, 'Individualising the dose of allopurinol in patients with gout', British Journal of Clinical Pharmacology, vol. 83, pp. 2015 - 2026, http://dx.doi.org/10.1111/bcp.13307

Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2017, 'A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function', European Journal of Clinical Pharmacology, vol. 73, pp. 981 - 990, http://dx.doi.org/10.1007/s00228-017-2251-1

Day RO; Kannangara DRW; Stocker SL; Carland JE; Williams KM; Graham GG, 2017, 'Allopurinol: insights from studies of dose–response relationships', Expert Opinion on Drug Metabolism and Toxicology, vol. 13, pp. 449 - 462, http://dx.doi.org/10.1080/17425255.2017.1269745

Kamel B; Graham GG; Williams KM; Pile KD; Day RO, 2017, 'Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat', Clinical Pharmacokinetics, vol. 56, pp. 459 - 475, http://dx.doi.org/10.1007/s40262-016-0466-4

Day RO; Kamel B; Kannangara DRW; Williams KM; Graham GG, 2016, 'Xanthine oxidoreductase and its inhibitors: Relevance for gout', Clinical Science, vol. 130, pp. 2167 - 2180, http://dx.doi.org/10.1042/CS20160010

Conference Papers:

Graham GG, 2000, 'Overview of methadone pharmacokinetics. Discussant paper.', in Workshop on the Induction and Stabilisation of patients onto methadone, Workshop on the Induction and Stabilisation of patients onto methadone, Adelaide, Sth Aust, presented at Workshop on the Induction and Stabilisation of patients onto methadone, Adelaide, Sth Aust, 28 - 29 January 1999

Graham GG; Quane PA; Wilson JL; Ziegler JB, 1998, 'Cellular effects of benzydamine', in NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, SPRINGER VERLAG, pp. R733 - R733, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000075207801371&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Ziegler JB; Graham GG; Day RO; Williams KM; Milligan MK, 1998, 'THERAPEUTIC CONSIDERATIONS FROM PHARMACOKINETICS AND METABOLISM: IBUPROFEN AND PARACETAMOL.', in Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, San Francisco, California USA, presented at Safety and Efficacy of non-prescription analgesics and NSAIDS, San Francisco, California USA, 17 - 01 March 1997

Graham GG; Duffull SB; Daly EB; Warwick NR; Torda TA, 1998, 'Predicting the time course of effect of atracurium from a pharmacokinetic-pharmacodynamic model', in Measurement and kinetics of invivo drug effects, Measurement and kinetics of invivo drug effects, Noordwijkerhout, The Netherlands, pp. 129 - 130, presented at Measurement and kinetics of invivo drug effects, Noordwijkerhout, The Netherlands, 27 - 30 May 1998

Graham GG; Kettle AJ; Milligan MK; Ziegler JB, 1998, 'Inhibition of the neutrophil enzyme, myeloperoxidase by paracetamol', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, ASCEPT: 32nd Annual Scientific Meeting, Hobart, pp. 180, presented at ASCEPT: 32nd Annual Scientific Meeting, Hobart, 01 December 1998

Other:

Kumar SS; Graham GG; Smith FC; Furlong TJ; Greenfield JR; Stocker SS; Carland JE; Day RO, 2017, Could metformin be used in patients with advanced chronic kidney disease?, http://dx.doi.org/10.1111/dom.12806

Conference Abstracts:

Kannangara D; Graham G; Wright D; Barclay M; Stamp L; Williams K; Day R, 2015, 'TREATING GOUT PATIENTS WITH ALLOPURINOL: A CONCENTRATION- OR DOSE-RESPONSE APPROACH?', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 13 - 13, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a